The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Biogenic Amines and Emotion: Pharmacological studies suggest a relationship between brain biogenic amines and affective state.
Abstract
The studies discussed here have shown a fairly consistent relationship between the effects of drugs on biogenic amines, particularly norepinephrine, and affective or behavioral states. Those drugs which cause depletion and inactivation of norepinephrine centrally produce sedation or depression, while drugs which increase or potentiate brain norepinephrine are associated with behavioral stimulation or excitement and generally have an antidepressant effect in man. From these findings, a number of investigators have formulated the concept, designated the catecholamine hypothesis of affective disorders, that some, if not all, depressions may be associated with a relative deficiency of norepinephrine at functionally important adrenergic receptor sites in the brain, whereas elations may be associated with an excess of such amines. It is not possible either to confirm or to reject this hypothesis on the basis of currently available clinical data. Although there does appear to be a fairly consistent relationship between the effects of pharmacological agents on norepinephrine metabolism and on affective state, a rigorous extrapolation from pharmacological studies to pathophysiology cannot be made. Confirmation of this hypothesis must ultimately depend upon direct demonstration of the biochemical abnormality in the naturally occurring illness. It should be emphasized, however, that the demonstration of such a biochemical abnormality would not necessarily imply a genetic or constitutional, rather than an environmental or psychological, etiology of depression. Whereas specific genetic factors may be of importance in the etiology of some, and possibly all, depressions, it is equally conceivable that early experiences of the infant or child may cause enduring biochemical changes and that these may predispose some individuals to depressions in adulthood. It is not likely that changes in the metabolism of the biogenic amines alone will account for the complex phenomena of normal or pathological affect. Whereas the effects of these amines at particular sites in the brain may be of crucial importance in the regulation of affect, any comprehensive formulation of the physiology of affective state will have to include many other concomitant biochemical, physiological, and psychological factors. Although in this review of the relationship of biogenic amines to affective state relatively little has been said concerning the intricate set of environmental and psychological determinants of emotion, the importance of these factors must be stressed. The normally occurring alterations in affective state induced by environmental events is well known to all, from personal experience. The interactions between such environmental determinants of affect, various physiological factors, and the complexity of psychological determinants, including cognitive factors derived from the individual's remote and immediate past experiences, have received only limited study under adequately controlled conditions. It may be anticipated, however, that this will prove to be a particularly fruitful area for future research, for only within such a multifactorial framework may one expect to understand fully the relationship of the biogenic amines to emotional state.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cognitive, social, and physiological determinants of emotional state.
Schachter, S., & Singer, J. (1962) · Psychological Review · doi:10.1037/h0046234 · Cited by 6,223
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
SCHILDKRAUT, J. J. (1965) · American Journal of Psychiatry · doi:10.1176/ajp.122.5.509 · Cited by 3,492
Self-citationOlds, J., & Milner, P. (1954) · Journal of Comparative and Physiological Psychology · doi:10.1037/h0058775 · Cited by 3,176
The James-Lange Theory of Emotions: A Critical Examination and an Alternative Theory
Cannon, W. B. (1927) · The American Journal of Psychology · doi:10.2307/1415404 · Cited by 1,899
LITHIUM SALTS IN THE TREATMENT OF PSYCHOTIC EXCITEMENT
Cade, J. F. J. (1949) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1949.tb36912.x · Cited by 1,463
3,4-Dihydroxyphenylalanine and 5-Hydroxytryptophan as Reserpine Antagonists
CARLSSON, A., LINDQVIST, M., & MAGNUSSON, T. (1957) · Nature · doi:10.1038/1801200a0 · Cited by 1,278
Lithium salts in the treatment of psychotic excitement
Cade, J. F. J. (1999) · Australian and New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.1999.06241.x · Cited by 1,150
Vogt, M. (1954) · The Journal of Physiology · doi:10.1113/jphysiol.1954.sp005064 · Cited by 1,012
The Physiological Differentiation between Fear and Anger in Humans
AX, A. F. (1953) · Psychosomatic Medicine · doi:10.1097/00006842-195309000-00007 · Cited by 895
Spector, S., Sjoerdsma, A., & Udenfriend, S. (1965) · PubMed · Cited by 812
A CONCEPT FOR A ROLE OF SEROTONIN AND NOREPINEPHRINE AS CHEMICAL MEDIATORS IN THE BRAIN
Brodie, B. B., & Shore, P. A. (1957) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1957.tb40753.x · Cited by 637
THE TREATMENT OF DEPRESSIVE STATES WITH G 22355 (IMIPRAMINE HYDROCHLORIDE)
KUHN, R. (1958) · American Journal of Psychiatry · doi:10.1176/ajp.115.5.459 · Cited by 615
ARCHIVES OF NEUROLOGY AND PSYCHIATRY
Mott, F. W. (1923) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-192304000-00071 · Cited by 576
GLOWINSKI, J., & AXELROD, J. (1964) · Nature · doi:10.1038/2041318a0 · Cited by 512
Hypothalamic Substrates of Reward
Olds, J. (1962) · Physiological Reviews · doi:10.1152/physrev.1962.42.4.554 · Cited by 469
ANTIAMPHETAMINE EFFECTS FOLLOWING INHIBITION OF TYROSINE HYDROXYLASE
Weissman, A., Koe, B. K., & Tenen, S. S. (1966) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)27265-2 · Cited by 451
DEPRESSION BY RESERPINE OF THE NORADRENALINE CONCENTRATION IN THE HYPOTHALAMUS OF THE CAT
Holzbauer, M., & Vogt, M. (1956) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1956.tb12048.x · Cited by 422
EFFECT OF DRUGS ON THE UPTAKE AND METABOLISM OF H3-NOREPINEPHRINE
HERTTING, G., AXELROD, J., & WHITBY, L. G. (1961) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)26144-4 · Cited by 375
POTENTIATION OF THE ANTIDEPRESSIVE EFFECT OF A MONOAMINE-OXIDASE INHIBITOR BY TRYPTOPHAN
Coppen, A., Shaw, D., & Farrell, J. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91084-5 · Cited by 344
Wolfstein, &. (1905) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-190502000-00009 · Cited by 344
Effects of Amino Acid Feedings in Schizophrenic Patients Treated with Iproniazid
Pollin, W., Cardon, P. V., & Kety, S. S. (1961) · Science · doi:10.1126/science.133.3446.104 · Cited by 339
Self-citationSerotonin Release as a Possible Mechanism of Reserpine Action
Pletscher, A., Shore, P. A., & Brodie, B. B. (1955) · Science · doi:10.1126/science.122.3165.374 · Cited by 336
EFFECT OF DRUGS ON THE UPTAKE, RELEASE, AND METABOLISM OF H3-NOREPINEPHRINE IN THE RAT BRAIN
Glowinski, J., & Axelrod, J. (1965) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)27077-x · Cited by 331
Adrenaline Synthesis: Control by the Pituitary Gland and Adrenal Glucocorticoids
Wurtman, R. J., & Axelrod, J. (1965) · Science · doi:10.1126/science.150.3702.1464 · Cited by 319
SELF-STIMULATION OF THE BRAIN AND THE CENTRAL STIMULANT ACTION OF AMPHETAMINE.
Stein, L. (1964) · PubMed · Cited by 313
The Role of Pleasure in Behavior
ALDRICH, K. C., & Heath, R. G. (1965) · Psychosomatic Medicine · doi:10.1097/00006842-196505000-00017 · Cited by 304
Blood-Brain Barrier for Adrenaline
Weil-Malherbe, H., Axelrod, J., & Tomchick, R. (1959) · Science · doi:10.1126/science.129.3357.1226 · Cited by 303
Clinical pharmacology of imipramine and related antidepressant compounds.
KLERMAN, G. L., & Cole, J. O. (1967) · PubMed · Cited by 272
METABOLISM OF [3H]NOREPINEPHRINE IN THE RAT BRAIN
Glowinski, J., Kopin, I. J., & Axelrod, J. (1965) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1965.tb10247.x · Cited by 259
Hillarp, N. ‐., Fuxé, K., & Dahlström, A. B. (1966) · PubMed · Cited by 242
STORAGE AND METABOLISM OF CATECHOLAMINES: THE ROLE OF MONOAMINE OXIDASE.
KOPIN, I. J. (1964) · PubMed · Cited by 235
CONVERSION OF ATRIAL FIBRILLATION TO SINUS RHYTHM BY DIRECT-CURRENT SHOCK
Oram, S., Davies, J. P. H., Weinbren, I., Taggart, P., & Kitchen, L. D. (1963) · The Lancet · doi:10.1016/s0140-6736(63)92799-5 · Cited by 234
MASON, J. W., MANGAN, G., BRADY, J. V., CONRAD, D., & RIOCH, D. M. (1961) · Psychosomatic Medicine · doi:10.1097/00006842-196107000-00011 · Cited by 192
Pharmacological Studies with Tofrānil
Sigg, E. B. (1959) · Canadian Psychiatric Association Journal · doi:10.1177/070674375900401s07 · Cited by 188
Boyland, E. J., & Haddow, A. (1964) · PubMed · Cited by 184
RELEASE OF SEROTONIN AND CATECHOLAMINES BY DRUGS
SHORE, P. A. (1962) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07057-7 · Cited by 180
Funkenstein, D. H., King, S. H., & Drolette, M. E. (1957) · Harvard University Press eBooks · doi:10.4159/harvard.9780674332911 · Cited by 177
ROLE OF BRAIN SEROTONIN IN RESERPINE ACTION
Shore, P. A., Pletscher, A., Tomich, E. G., Carlsson, A., Kuntzman, R., & Brodie, B. B. (1957) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1957.tb40751.x · Cited by 173
STORAGE AND SYNTHESIS OF NOREPINEPHRINE IN THE RESERPINE-TREATED RAT BRAIN
Glowinski, J., Iversen, L. L., & Axelrod, J. (1966) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)27270-6 · Cited by 164
5-Hydroxyindoles in Human Cerebrospinal Fluids
ASHCROFT, G. W., & SHARMAN, D. F. (1960) · Nature · doi:10.1038/1861050a0 · Cited by 163
METABOLISM OF NOREPINEPHRINE-H3 RELEASED BY TYRAMINE AND RESERPINE
Kopin, I. J., & Gordon, E. K. (1962) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)26437-0 · Cited by 155
Stein, L., & Himwich, H. E. (1962) · Springer eBooks · doi:10.1007/978-1-4684-8306-2_27 · Cited by 150
A CLINICAL AND BIOCHEMICAL STUDY OF A TRIAL OF IPRONIAZID IN THE TREATMENT OF DEPRESSION
Pare, C. M. B., & Sandler, M. B. (1959) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.22.3.247 · Cited by 149
Tryptamine Metabolism in Depression
Coppen, A. J., Shaw, D. M., Malleson, A., Eccleston, E., & Gundy, G. H. (1965) · The British Journal of Psychiatry · doi:10.1192/bjp.111.479.993 · Cited by 148
THE ROLE OF BRAIN SEROTONIN IN THE MECHANISM OF THE CENTRAL ACTION OF RESERPINE
Brodie, B. B., Comer, M. S., Costa, E., & Dlabač, A. (1966) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)27328-1 · Cited by 148
Central-Nervous-System Effects of Ingestion of L-Tryptophan by Normal Subjects
Smith, B., & Prockop, D. J. (1962) · New England Journal of Medicine · doi:10.1056/nejm196212272672603 · Cited by 143
Adrenaline and Noradrenaline output in Urine After Unilateral and Bilateral Adrenalectomy in Man
von Euler, U. S., FRANKSSON, C., & Hellström, J. (1954) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1954.tb01107.x · Cited by 139
Sulser, F., Bickel, M. H., & Brodie, B. B. (1964) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)26795-7 · Cited by 135
Catecholamine metabolism in affective disorders: I.
Schildkraut, J. J., Gordon, E. K., & Durell, J. (1965) · Journal of Psychiatric Research · doi:10.1016/0022-3956(65)90003-8 · Cited by 135
Self-citationDEPRESSION AND ANXIETY OCCURRING DURING RAUWOLFIA THERAPY
Muller, J. C. (1955) · JAMA · doi:10.1001/jama.1955.02960260006002 · Cited by 134
Behavioral effects of -α-methyltyrosine, an inhibitor of tyrosine hydroxylase
Weissman, A., & Koe, B. K. (1965) · Life Sciences · doi:10.1016/0024-3205(65)90223-7 · Cited by 132
The Urinary Output of Adrenalin and Noradrenalin During Pleasant and Unpleasant Emotional States
Levi, L. (1965) · Psychosomatic Medicine · doi:10.1097/00006842-196501000-00009 · Cited by 132
Degkwitz, R., Frowein, R. A., Kulenkampff, C., & Mohs, U. (1960) · Journal of Molecular Medicine · doi:10.1007/bf02189076 · Cited by 126
EFFECTS OF d-AMPHETAMINE UPON BRAIN AMINE CONTENT AND LOCOMOTOR ACTIVITY OF MICE
Smith, C. B. (1965) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)26955-5 · Cited by 125
Mechanism of action of cocaine and amphetamine in the brain
van Rossum, J. M., van der Schoot, J. B., & Hurkmans, J. A. T. M. (1962) · Cellular and Molecular Life Sciences · doi:10.1007/bf02148316 · Cited by 122
Smith, C. B. (1963) · PubMed · Cited by 122
Emotional effects produced by the injection of adrenalin
Cantril, H., & Hunt, W. A. (1932) · The American Journal of Psychology · doi:10.2307/1414829 · Cited by 119
The effects of lithium ion on H3 -norepinephrine metabolism in brain
Schildkraut, J. J., Schanberg, S. M., & Kopin, I. J. (1966) · Life Sciences · doi:10.1016/0024-3205(66)90221-9 · Cited by 119
Self-citationEisenfeld, A. J., Axelrod, J., & Krakoff, L. R. (1967) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)27601-7 · Cited by 118
MODIFICATIONS OF THE PHARMACOLOGY OF RESERPINE AND SEROTONIN BY IPRONIAZID
Chessin, M., Kramer, E. R., & Scott, C. C. (1957) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11898-3 · Cited by 112
THE UPTAKE AND STORAGE OF H3-NOREPINEPHRINE IN THE RESERPINE-PRETREATED RAT HEART
Iversen, L. L., Glowinski, J., & Axelrod, J. (1965) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)27167-1 · Cited by 104
Effect of Flying on the Epinephrine Excretion in Air Force Personnel
von Euler, U. S., & Lundberg, U. (1954) · Journal of Applied Physiology · doi:10.1152/jappl.1954.6.9.551 · Cited by 102
Ström-Olsen, R., & Weil‐Malherbe, H. (1958) · Journal of Mental Science · doi:10.1192/bjp.104.436.696 · Cited by 99
THE PSYCHOPHYSIOLOGY OF ANXIETY: WITH A REVIEW OF THE LITERATURE CONCERNING ADRENALINE
Breggin, P. R. (1964) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-196412000-00009 · Cited by 98
Scheckel, C. L., & Boff, E. (1964) · Psychopharmacology · doi:10.1007/bf00413242 · Cited by 94
Hanson, L. C. F. (1965) · Psychopharmacology · doi:10.1007/bf00404170 · Cited by 94
Iproniazid (marsilid) phosphate, a therapeutic agent for mental disorders and debilitating diseases.
Crane, G. E. (1957) · PubMed · Cited by 94
Achor, R. W. P. (1955) · JAMA · doi:10.1001/jama.1955.02960260011004 · Cited by 91
THE PHARMACOLOGY AND BIOCHEMISTRY OF DEPRESSION.
Prange, A. J. (1964) · PubMed · Cited by 91
Norepinephrine: A possible excitatory neurohormone of the reward system
Poschel, B. P. H., & Ninteman, F. W. (1963) · Life Sciences · doi:10.1016/0024-3205(63)90087-0 · Cited by 89
Potentiation of the behavioral effects of amphetamine by imipramine
Carlton, P. L. (1961) · Psychopharmacology · doi:10.1007/bf00404124 · Cited by 87
Disclosure of Labile Monoamine Fractions in Brain and Their Correlation to Behaviour
Häggendal, J., & Lindqvist, M. (1964) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1964.tb02897.x · Cited by 85
Effects of d-amphetamine and restraint on the content of norepinephrine and dopamine in rat brain
Moore, K. E., & Lariviere, E. W. (1963) · Biochemical Pharmacology · doi:10.1016/0006-2952(63)90196-5 · Cited by 83
PSYCHOTOMIMETIC DRUGS AND BRAIN BIOGENIC AMINES
Freedman, D. X. (1963) · American Journal of Psychiatry · doi:10.1176/ajp.119.9.843 · Cited by 82
Depressive states during Rauwolfia therapy for arterial hypertension; a report of 30 cases.
Lemieux, G. G. F., Davignon, A., & Genest, J. J. (1956) · PubMed · Cited by 81
Possible Mode of Antidepressive Action of Imipramine
Stein, L., & Seifter, J. (1961) · Science · doi:10.1126/science.134.3474.286 · Cited by 80
Brain Catecholamines: Relation to the Defense Reaction Evoked by Amygdaloid Stimulation in Cat
Reis, D. J., & Gunne, L.-M. (1965) · Science · doi:10.1126/science.149.3682.450 · Cited by 80
Brodie, B. B., Finger, K. F., Orlans, F. B., et al. (1960) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)25818-9 · Cited by 79
Clinical experience with dihydroxyphenylalanine (DOPA) in depression
Klerman, G. L., Schildkraut, J. J., Ll, H., Greenblatt, M., & Friend, D. G. (1963) · Journal of Psychiatric Research · doi:10.1016/0022-3956(63)90004-9 · Cited by 79
Self-citationWurtman, R. J. (1965) · New England Journal of Medicine · doi:10.1056/nejm196509162731205 · Cited by 76
FURTHER STUDIES ON: ONE DAY TREATMENT OF DEPRESSION WITH 5-HTP
Kline, N. S., Sacks, W., & Simpson, G. M. (1964) · American Journal of Psychiatry · doi:10.1176/ajp.121.4.379 · Cited by 66
Correlation between noradrenaline uptake and adrenergic nerve function after reserpine treatment
Andén, N., Magnusson, T., & Waldeck, B. (1964) · Life Sciences · doi:10.1016/0024-3205(64)90221-8 · Cited by 66
Changes in 5-Hydroxytryptophan Metabolism in Depression
Coppen, A. J., Shaw, D. M., & Malleson, A. (1965) · The British Journal of Psychiatry · doi:10.1192/bjp.111.470.105 · Cited by 60
COMMENT: DEPRESSION INDUCED BY RAUWOLFIA COMPOUNDS
H., T. H. (1957) · American Journal of Psychiatry · doi:10.1176/ajp.113.10.950 · Cited by 60
Therapeutic Efficacy of Antidepressant Drugs: A Review
Cole, J. O. (1964) · JAMA · doi:10.1001/jama.1964.03070180046007 · Cited by 59
RELIEF OF DEPRESSION WITHIN ONE DAY USING AN M.A.O. INHIBITOR AND INTRAVENOUS 5-HTP
Kline, N. S., & Sacks, W. (1963) · American Journal of Psychiatry · doi:10.1176/ajp.120.3.274 · Cited by 58
Effects of stress and D-amphetamine on rat brain catecholamines
Moore, K. E., & Lariviere, E. W. (1964) · Biochemical Pharmacology · doi:10.1016/0006-2952(64)90107-8 · Cited by 56
INTERRELATIONSHIPS BETWEEN ELECTROSHOCK, THE BLOOD BRAIN BARRIER, AND CATECHOLAMINES*
Rosenblatt, S., Chanley, J. D., Sobotka, H., & Kaufman, M. (1960) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1960.tb13350.x · Cited by 53
Imipramine Hydrochloride: Its Effects on Clinical, Autonomic, and Psychological Functions
Gershon, S., HOLMBERG, G., MATTSSON, E., Mattsson, N., & MARSHALL, A. (1962) · Archives of General Psychiatry · doi:10.1001/archpsyc.1962.01710190098011 · Cited by 52
Curtis, G. C., CLEGHORN, R. A., & Sourkes, T. L. (1960) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(60)90009-x · Cited by 49
Hordern, A. (1965) · New England Journal of Medicine · doi:10.1056/nejm196506032722206 · Cited by 49
Normetanephrine Excretion and Affective State in Depressed Patients Treated with Imipramine
Schildkraut, J. J., GREEN, R., Gordon, E. K., & Durell, J. (1966) · American Journal of Psychiatry · doi:10.1176/ajp.123.6.690 · Cited by 48
Self-citationCombined administration of desipramine and reserpine or tetrabenazine in depressive patients
P�ldinger, W. (1963) · Psychopharmacology · doi:10.1007/bf00408187 · Cited by 45
Catecholamines in neuropsychiatric states.
Kety, S. S. (1966) · PubMed · Cited by 45
Self-citationPoschel, B. P. H., & Ninteman, F. W. (1964) · Life Sciences · doi:10.1016/0024-3205(64)90155-9 · Cited by 43
Differences in the Metabolism of Norepinephrine in Depressions
Rosenblatt, S. (1965) · Archives of General Psychiatry · doi:10.1001/archpsyc.1965.01730060013002 · Cited by 34
Anxiety and Performance Changes with Minimal Dose of Epinephrine
Basowitz, H., KORCHIN, S. J., OKEN, D., GOLDSTEIN, M. S., & GUSSACK, H. (1956) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1956.02330250100015 · Cited by 33
Pollin, W., & Goldin, S. (1961) · Journal of Psychiatric Research · doi:10.1016/0022-3956(61)90006-1 · Cited by 32
Schildkraut, J. J., Klerman, G. L., Friend, D. G., et al. (1963) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1963.tb13344.x · Cited by 32
Self-citationBiological Aspects of Electroconvulsive Therapy
Holmberg, G. (1963) · International review of neurobiology · doi:10.1016/s0074-7742(08)60600-5 · Cited by 26
Wearn, J. T. (1919) · Archives of Internal Medicine · doi:10.1001/archinte.1919.00090260002001 · Cited by 25
The Metabolism of the Catecholamines (Clinical Implications)
COHEN, R. A., BRIDGERS, W. F., Axelrod, J., WEIL-MALHERBE, H., LABROSSE, E. H., Bunney, W. E., CARDON, P. V., & KETY, S. S. (1962) · Annals of Internal Medicine · doi:10.7326/0003-4819-56-6-960 · Cited by 24
Self-citationWurtman, R. J. (1965) · New England Journal of Medicine · doi:10.1056/nejm196509232731306 · Cited by 23
Cited by
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
“The monoamine hypothesis is the most extensively studied tiologic theory of depression (7,8) and virtually all available ntidepressants act, at least in part, by increasing monoaminergic ransmission.”
BackgroundRethinking the Emotional Brain
LeDoux, J. (2012) · Neuron · doi:10.1016/j.neuron.2012.02.004 · Cited by 1,594
“That is, they modulate rather than initiate neural activity, regulating neuronal excitability and neurotransmission (Schildkraut and Kety, 1967; Hasselmo, 1995; Lopez and Brown, 1992).”
Jouvet, M. (1972) · Neurophysiology and Neurochemistry of Sleep and Wakefulness · doi:10.1007/3-540-05462-6_2 · Cited by 1,098
CATECHOLAMINES IN FETAL AND NEWBORN RAT BRAIN
Coyle, J. T., & Henry, D. (1973) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1973.tb04225.x · Cited by 781
The Brain Nucleus Locus Coeruleus: Restricted Afferent Control of a Broad Efferent Network
Aston-Jones, G., Ennis, M., Pieribone, V. A., Nickell, W. T., & Shipley, M. T. (1986) · Science · doi:10.1126/science.3775363 · Cited by 778
Metadata
- Authors
- Schildkraut, J. J., & Kety, S. S.
- Venue
- Science
- Published
- 1967-04-07
- Volume
- 156
- Issue
- 3771
- Pages
- 21-30
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2081494794
- Cited by
- 875
- References
- 103
- FWCI
- 25.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.